Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage

The Lancet Neurology

Volumn 10, Issue 4, 2011, Pages 349-356

  Rinkel, Gabriel JE ^a   Algra, Ale ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RIVASTIGMINE;

ALZHEIMER DISEASE; ANEURYSM CLIP; ANEURYSM RUPTURE; ANOSMIA; BRAIN ARTERY ANEURYSM; CARDIOVASCULAR DISEASE; COGNITIVE DEFECT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COPING BEHAVIOR; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEALTH CARE COST; HEARING DISORDER; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LIFE EXPECTANCY; LIFE SATISFACTION; MOOD DISORDER; MORTALITY; ONSET AGE; OUTCOMES RESEARCH; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANKIN SCALE; RECURRENT DISEASE; REHABILITATION CARE; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; SCREENING; SECONDARY PREVENTION; SMOKING CESSATION; STROKE; SUBARACHNOID HEMORRHAGE; SURVIVAL RATE; TEAMWORK; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

BRAIN; COGNITION DISORDERS; HUMANS; MOOD DISORDERS; QUALITY OF LIFE; RECOVERY OF FUNCTION; RISK FACTORS; SECONDARY PREVENTION; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

EID: 79952724609     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(11)70017-5     Document Type: Review

References (76)

1. de Rooij NK, Linn FHH, van der Plas JA, Algra A, Rinkel GJE Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 2007, 78:1365-1372.
2. Koffijberg H, Buskens E, Granath F, et al. Subarachnoid haemorrhage in Sweden 1987-2002: regional incidence and case fatality rates. J Neurol Neurosurg Psychiatry 2008, 79:294-299.
3. Nieuwkamp DJ, Setz LE, Algra A, Linn FH, de Rooij NK, Rinkel GJE Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol 2009, 8:635-642.
4. Lovelock CE, Rinkel GJE, Rothwell PM Time trends in outcome of subarachnoid hemorrhage. Population-based study and systematic review. Neurology 2010, 74:1494-1501.
5. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009, 8:355-369.
6. Huang J, van Gelder JM The probability of sudden death from rupture of intracranial aneurysms: a meta-analysis. Neurosurgery 2002, 51:1101-1105.
7. Remaining (healthy) life expectancy CBS, (accessed Aug 29, 2010). http://www.cbs.nl/en-GB/menu/themas/gezondheid-welzijn/cijfers/extra/resterende-gezonde-levensverwachting.htm?Languageswitch=on.
8. Rinkel GJE, Djibuti M, Algra A, van Gijn J Prevalence and risk of rupture of intracranial aneurysms: a systematic review. Stroke 1998, 29:251-256.
9. Ruigrok YM, Buskens E, Rinkel GJE Attributable risk of common and rare determinants of subarachnoid hemorrhage. Stroke 2001, 32:1173-1175.
10. Tsutsumi K, Ueki K, Usui M, Kwak S, Kirino T Risk of recurrent subarachnoid hemorrhage after complete obliteration of cerebral aneurysms. Stroke 1998, 29:2511-2513.
11. Wermer MJH, Greebe P, Algra A, Rinkel GJE Incidence of recurrent subarachnoid subarachnoid hemorrhage after clipping for ruptured intracranial aneurysms. Stroke 2005, 36:2394-2399.
12. Rates of delayed rebleeding from intracranial aneurysms are low after surgical and endovascular treatment. Stroke 2006, 37:1437-1442. CARAT investigators.
13. Molyneux AJ, Kerr RS, Birks J, et al. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009, 8:427-433. for the ISAT collaborators.
14. Schaafsma JD, Sprengers ME, van Rooij WJ, et al. Long-term recurrent subarachnoid hemorrhage after adequate coiling versus clipping of ruptured intracranial aneurysms. Stroke 2009, 40:1758-1763.
15. Choi DS, Kim MC, Lee SK, Willinsky RA, Terbrugge KG Clinical and angiographic long-term follow-up of completely coiled intracranial aneurysms using endovascular technique. J Neurosurg 2010, 112:575-581.
16. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke 2000, 31:1843-1850.
17. van der Schaaf IC, Velthuis BK, Wermer MJH, et al. New detected aneurysms on follow-up screening in patients with previously clipped intracranial aneurysms: comparison with DSA or CTA at time of the SAH. Stroke 2005, 36:1753-1758.
18. Wermer MJH, van der Schaaf IC, Velthuis BK, et al. Follow-up screening after subarachnoid haemorrhage: frequency and determinants of new aneurysms and enlargement of existing aneurysms. Brain 2005, 128:2421-2429.
19. Feigin VL, Rinkel GJE, Lawes CMM, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005, 36:2773-2780.
20. Ronkainen A, Niskanen M, Rinne J, Koivisto T, Hernesniemi J, Vapalahti M Evidence for excess long-term mortality after treated subarachnoid hemorrhage. Stroke 2001, 32:2850-2853.
21. Wermer MJH, Greebe P, Algra A, Rinkel GJE Long-term mortality and vascular event risk after aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2009, 80:1399-1401.
22. Nieuwkamp DJ, Algra A, Blomqvist P, et al. Excess mortality and cardiovascular events in patients surviving subarachnoid hemorrhage: a nationwide study in Sweden. Stroke 2011, published online Feb 17. 10.1161/STROKEAHA.110.602722.
23. van Heuven AW, Dorhout Mees SM, Algra A, Rinkel GJE Validation of a prognostic subarachnoid hemorrhage grading scale derived directly from the Glasgow Coma Scale. Stroke 2008, 39:1347-1348.
24. Haug T, Sorteberg A, Finset A, Lindegaard KF, Lundar T, Sorteberg W Cognitive functioning and health-related quality of life 1 year after aneurysmal subarachnoid hemorrhage in preoperative comatose patients (Hunt and Hess Grade V patients). Neurosurgery 2010, 66:475-484.
25. Harrison N, Wilson FC Independent living following a 'do not resuscitate' order after subarachnoid haemorrhage. Disabil Rehabil 2007, 29:347-352.
26. Greebe P, Rinkel GJE, Algra A Long-term outcome of patients discharged to a nursing home after aneurysmal subarachnoid hemorrhage. Arch Phys Med Rehabil 2010, 91:247-251.
27. Mayer SA, Kreiter KT, Copeland D, et al. Global and domain-specific cognitive impairment and outcome after subarachnoid hemorrhage. Neurology 2002, 59:1750-1758.
28. Al-Khindi T, Macdonald RL, Schweizer TA Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage. Stroke 2010, 41:e519-e536.
29. Passier PE, Visser-Meily JM, van Zandvoort MJ, Post MW, Rinkel GJ, van Heugten C Prevalence and determinants of cognitive complaints after aneurysmal subarachnoid hemorrhage. Cerebrovasc Dis 2010, 29:557-563.
30. Haug T, Sorteberg A, Sorteberg W, Lindegaard KF, Lundar T, Finset A Cognitive outcome after aneurysmal subarachnoid hemorrhage: time course of recovery and relationship to clinical, radiological, and management parameters. Neurosurgery 2007, 60:649-656.
31. Samra SK, Giordani B, Caveney AF, et al. Recovery of cognitive function after surgery for aneurysmal subarachnoid hemorrhage. Stroke 2007, 38:1864-1872.
32. Hackett ML, Anderson CS Health outcomes 1 year after subarachnoid hemorrhage. An international population-based study. Neurology 2000, 55:658-662. for the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS) Group.
33. Scott RB, Eccles F, Molyneux AJ, Kerr RS, Rothwell PM, Carpenter K Improved cognitive outcomes with endovascular coiling of ruptured intracranial aneurysms: neuropsychological outcomes from the International Subarachnoid Aneurysm Trial (ISAT). Stroke 2010, 41:1743-1747.
34. Bendel P, Koivisto T, Hanninen T, et al. Subarachnoid hemorrhage is followed by temporomesial volume loss: MRI volumetric study. Neurology 2006, 67:575-582.
35. Bendel P, Koivisto T, Kononen M, et al. MR imaging of the brain 1 year after aneurysmal subarachnoid hemorrhage: randomized study comparing surgical with endovascular treatment. Radiology 2008, 246:543-552.
36. Bendel P, Koivisto T, Niskanen E, et al. Brain atrophy and neuropsychological outcome after treatment of ruptured anterior cerebral artery aneurysms: a voxel-based morphometric study. Neuroradiology 2009, 51:711-722.
37. Bendel P, Koivisto T, Aikia M, et al. Atrophic enlargement of CSF volume after subarachnoid hemorrhage: correlation with neuropsychological outcome. AJNR Am J Neuroradiol 2010, 31:370-376.
38. Powell J, Kitchen N, Heslin J, Greenwood R Psychosocial outcomes at 18 months after good neurological recovery from aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiat 2004, 75:1119-1124.
39. Morris PG, Wilson JT, Dunn L Anxiety and depression after spontaneous subarachnoid hemorrhage. Neurosurgery 2004, 54:47-54.
40. Noble AJ, Schenk T Posttraumatic stress disorder in the family and friends of patients who have suffered spontaneous subarachnoid hemorrhage. J Neurosurg 2008, 109:1027-1033.
41. Schuiling WJ, Rinkel GJE, Walchenbach R, de Weerd AW Disorders of sleep and wake in patients after subarachnoid hemorrhage. Stroke 2005, 36:578-582.
42. Visser-Meily JM, Rhebergen ML, Rinkel GJE, van Zandvoort MJ, Post MW Long-term health-related quality of life after aneurysmal subarachnoid hemorrhage: relationship with psychological symptoms and personality characteristics. Stroke 2009, 40:1526-1529.
43. Hummel T, Nordin S Olfactory disorders and their consequences for quality of life. Acta Otolaryngol 2005, 125:116-121.
44. Blomqvist EH, Bramerson A, Stjarne P, Nordin S Consequences of olfactory loss and adopted coping strategies. Rhinology 2004, 42:189-194.
45. Wermer MJ, Donswijk M, Greebe P, Verweij BH, Rinkel GJE Anosmia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2007, 61:918-922.
46. Martin GE, Junque C, Juncadella M, Gabarros A, de Miquel MA, Rubio F Olfactory dysfunction after subarachnoid hemorrhage caused by ruptured aneurysms of the anterior communicating artery. Clinical article. J Neurosurg 2009, 111:958-962.
47. De Vries J, Menovsky T, Ingels K Evaluation of olfactory nerve function after aneurysmal subarachnoid hemorrhage and clip occlusion. J Neurosurg 2007, 107:1126-1129.
48. Greebe P, Rinkel GJE, Algra A Anosmia after perimesencephalic nonaneurysmal hemorrhage. Stroke 2009, 40:2885-2886.
49. Kumar N Superficial siderosis: associations and therapeutic implications. Arch Neurol 2007, 64:491-496.
50. Kang S Hearing loss after surgery of ruptured cerebral aneurysm. Br J Neurosurg 2001, 15:258-263.
51. Passier PE, Visser-Meily JM, Rinkel GJE, Lindeman E, Post MW Life satisfaction and return to work after aneurysmal subarachnoid hemorrhage. J Stroke Cerebrovasc Dis 2010, published online July 24. 10.1016/j.jstrokecerebrovasdis.2010.02.001.
52. Wermer MJ, Kool H, Albrecht KW, Rinkel GJ Subarachnoid hemorrhage treated with clipping: long-term effects on employment, relationships, personality, and mood. Neurosurgery 2007, 60:91-97.
53. Greebe P, Rinkel GJE, Hop JW, Visser-Meily JMA, Algra A Functional outcome and quality of life 5 and 12·5 years after aneurysmal subarachnoid haemorrhage. J Neurol 2010, 257:2059-2064.
54. Johnston SC, Selvin S, Gress DR The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 1998, 50:1413-1418.
55. Qureshi AI, Suri MF, Nasar A, et al. Changes in cost and outcome among US patients with stroke hospitalized in 1990 to 1991 and those hospitalized in 2000 to 2001. Stroke 2007, 38:2180-2184.
56. Hop JW, Rinkel GJE, Algra A, van Gijn J Changes in functional outcome and quality of life in patients and caregivers after aneurysmal subarachnoid hemorrhage. J Neurosurg 2001, 95:957-963.
57. Rivero-Arias O, Gray A, Wolstenholme J Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc 2010, 8:6.
58. King JT, Horowitz MB, Bissonette DJ, Tsevat J, Roberts MS What do patients with cerebral aneurysms know about their condition?. Neurosurgery 2006, 58:824-830.
59. Vogelsang AC, Wengstrom Y, Forsberg C Patient information after ruptured intracranial aneurysm. J Adv Nurs 2004, 48:551-559.
60. Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011, 42:227-276.
61. Treating tobacco use and dependence: 2008 update US Department of Health and Human Services, (accessed Jan 20, 2011). http://www.surgeongeneral.gov/tobacco/treating_tobacco_use08.pdf.
62. Wermer MJ, Koffijberg H, van der Schaaf IC Effectiveness and costs of screening for aneurysms every 5 years after subarachnoid hemorrhage. Neurology 2008, 70:2053-2062. for the ASTRA Study Group.
63. Wermer MJ, Rinkel GJE, Greebe P, Albrecht KW, Dirven CM, Tulleken CA Late recurrence of subarachnoid hemorrhage after treatment for ruptured aneurysms: patient characteristics and outcomes. Neurosurgery 2005, 56:197-204.
64. Bor AS, Rinkel GJE, Adami J, et al. Risk of subarachnoid haemorrhage according to number of affected relatives: a population based case-control study. Brain 2008, 131:2662-2665.
65. Bor ASE, Koffijberg H, Wermer MJ, Rinkel GJE Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis. Neurology 2010, 74:1671-1679.
66. Bossuyt PM, Raaymakers TWM, Bonsel GJ, Rinkel GJE Screening families for intracranial aneurysms: Anxiety, perceived risk, and informed choice. Prev Med 2005, 41:795-799.
67. Rinkel GJE Intracranial aneurysm screening: indications and advice for practice. Lancet Neurol 2005, 4:122-128.
68. van der Schaaf IC, Wermer MJ, Velthuis BK, Buskens E, Bossuyt PM, Rinkel GJE Psychosocial impact of finding small aneurysms that are left untreated in patients previously operated on for ruptured aneurysms. J Neurol Neurosurg Psychiatry 2006, 77:748-752.
69. Wermer MJ, van der Schaaf IC, Van Nunen P, Bossuyt PM, Anderson CS, Rinkel GJE Psychosocial impact of screening for intracranial aneurysms in relatives with familial subarachnoid hemorrhage. Stroke 2005, 36:836-840.
70. Wermer MJ, van der Schaaf IC, Velthuis BK, Majoie CB, Albrecht KW, Rinkel GJE Yield of short-term follow-up CT/MR angiography for small aneurysms detected at screening. Stroke 2006, 37:414-418.
71. Koffijberg H, Buskens E, Algra A, Wermer MJ, Rinkel GJE Growth rates of intracranial aneurysms: exploring constancy. J Neurosurg 2008, 109:176-185.
72. Wald NJ, Law MR A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003, 326:1419.
73. de Rooij NK, Velthuis BK, Algra A, Rinkel GJE Configuration of the circle of Willis, direction of flow, and shape of the aneurysm as risk factors for rupture of intracranial aneurysms. J Neurol 2009, 256:45-50.
74. van der Kolk NM, Algra A, Rinkel GJE Risk of aneurysm rupture at intracranial arterial bifurcations. Cerebrovasc Dis 2010, 30:29-35.
75. Wong GK, Wong R, Mok V, et al. Rivastigmine for cognitive impairment after spontaneous subarachnoid haemorrhage: a pilot study. J Clin Pharm Ther 2009, 34:657-663.
76. Takata K, Sheng H, Borel CO, Laskowitz DT, Warner DS, Lombard FW Simvastatin treatment duration and cognitive preservation in experimental subarachnoid hemorrhage. J Neurosurg Anesthesiol 2009, 21:326-333.